Requires manufacturers or distributers of kratom within the state to include a warning label; prohibits labeling of kratom products as all natural

New warning and marketing rules for kratom

The law covers kratom, or Mitragyna speciosa, and products derived from its leaves marketed as herbal supplements. Beginning January 1, 2026, manufacturers selling or delivering kratom products in New York must put this warning on each package: “WARNING This product has not been approved by the FDA. Side effects may include nausea, agitation, hallucinations, difficulty breathing, liver damage, and death.” The warning must use at least 12-point type and a color that contrasts with the package. Kratom ads and packaging cannot call the product “all natural” or suggest that it is. Violations carry civil penalties up to $500 for a first violation and $1,000 for a second or later violation. The act takes effect one year after becoming law, with January 1, 2026 specified for package warnings.